Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

New Scientific Review Confirms Blood Clots in Leg and Lungs (VTE) - No. 3 Cardiovascular Killer Globally - Is Leading Cause of Premature Death and Disability in Hospitals


News provided by

International Society on Thrombosis and Haemostasis

10 Oct, 2014, 00:01 GMT

Share this article

Share toX

Share this article

Share toX

-- World Thrombosis Day launches to bring awareness to largely preventable disease as comprehensive science review and public survey reveal large gap in public's knowledge 

CHAPEL HILL, North Carolina, Oct. 10, 2014 /PRNewswire/ -- While the world's top two cardiovascular killers – heart attack and stroke – are global health priorities, the No. 3 killer, venous thromboembolism (VTE) or blood clots in the leg and lungs, has remained largely unaddressed and under-recognized by the public, according to the most comprehensive scientific review of the global burden of VTE ever undertaken and a global public survey. To address this disconnect, the International Society of Thrombosis and Haemostasis (ISTH) is leading a global effort together with more than 175 health/medical and patient organizations around the world to launch World Thrombosis Day (WTD), focused initially on increasing public and health professionals' awareness of potentially deadly blood clots in the leg and lungs, the risk factors, symptoms and the importance of prevention.

Continue Reading
This image opens in the lightbox
World Thrombosis Day on October 13 (PRNewsFoto/ISTH)

Logo - http://photos.prnewswire.com/prnh/20141006/150462

"The lack of attention over decades to this largely preventable disease amounts to an unrecognized crisis that we must start addressing immediately," said Gary Raskob, Ph.D., corresponding author of the scientific review, dean of the College of Public Health, University of Oklahoma Health Center and chairman of the WTD Steering Committee. "It is clear from our review that VTE is a major contributor to global disease burden. We must work together to increase awareness at all levels – personal, health care systems and providers, and ultimately policy makers – and to do a better job of prevention."

SCIENTIFIC REVIEW HIGHLIGHTS

Published in the Journal of Thrombosis and Haemostasis (JTH)[*] and four other leading thrombosis journals simultaneously worldwide, highlights from the review include:

  • VTE is a major contributor to the global disease burden across high-, middle- and low-income regions, with overall incidence ranging from 0.75 to 2.7 cases per 1,000 people.
  • VTE should be given higher priority in global disease surveillance and should be included in the World Health Organization (WHO) and World Bank's Global Burden of Disease, Injuries, and Risk Factors Study (GBD Study). The 2010 GBD Study documents the major impact of arterial thrombosis (blood clots in the arteries), the underlying cause of heart attacks and stroke, but does not include VTE as a specific cause of death and disability.
  • VTE was the leading cause of premature death and disability among the causes of hospital-associated adverse events evaluated by the WHO patient safety program.[†]
  • VTE prevention must be a global health priority, specifically the systematic and consistent use of proven, evidence-based preventive measures against VTE. This should be a priority for health-care providers and health systems as VTE is largely preventable. Simultaneously, the public must be made aware of the disease and how to prevent it – and they must be encouraged to be proactive about talking about it with their health care providers.

GLOBAL PUBLIC SURVEY HIGHLIGHTS

A survey conducted this summer among men and women in nine countries, conducted on behalf of ISTH by the global research firm Ipsos, found:

  • Among adults, an average of only about 50 percent were aware of, or had ever heard of the term pulmonary embolism and 44 percent were aware of or had heard the term deep vein thrombosis.
  • Only an average 1/4 of respondents were aware that hospital stays, surgery and cancer were the major risk factors for VTE.
  • Only 28 percent of respondents said they would know what a blood clot in the leg would feel like. However, 35 percent of those individuals misidentified the signs of a blood clot. Only 19 percent said that they know what a blood clot in the lungs – a pulmonary embolism – would feel like.
  • The majority of respondents were not aware that most blood clots can be prevented; 55 percent of individuals either were not aware that they can often be prevented or expressed no opinion about this question.

"Too few people know about blood clots in the leg and lungs and their life-threatening consequences – and too many people are dying a preventable death," said Raskob. "It is critical for people to: (1) Know the risk factors; (2) Be proactive – talk to your doctor about your risk and ask about preventing blood clots, especially if you are admitted to a hospital or are having surgery; and, (3) Know the symptoms and signs of a deep-vein thrombosis and of a pulmonary embolism and seek medical attention promptly if you experience them."

NEW PUBLIC EDUCATION RESOURCE

As part of the inaugural WTD launch, the ISTH has launched WorldThrombosisDay.org, a central informational resource to help the public understand the two types of blood clots that comprise VTE – those in the leg, called deep vein thrombosis (DVT), and those in the lungs, called pulmonary embolism (PE) – including an at-a-glance infographic and specific information about risk factors, signs/symptoms and key questions to ask health care providers, to FAQs, key terms to know, two public awareness videos and personal stories from patients and their families. The site also features resources and patient handouts for health professionals to help foster more dialogue between health care providers and the public.

[*] ISTH Steering Committee for World Thrombosis (2014). Thrombosis: A major contributor to global disease burden. J Thromb Haemost 2014; DOI: 10.1111/jth.12698; 12: 1580–1590.

[†] Jha AK, Larizgoitia I, Audera-Lopez C, Prasopa-Plaizier N, Waters H, Bates DW. The global burden of unsafe medical care: analytic modelling of observational studies. BMJ Qual Saf 2013; 22: 809−15.

Modal title

Also from this source

World Thrombosis Day raises global awareness of blood clot dangers through actionable initiatives

World Thrombosis Day raises global awareness of blood clot dangers through actionable initiatives

Today is World Thrombosis Day, a global campaign established by the International Society on Thrombosis and Haemostasis (ISTH) to engage the general...

ISTH announces launch of new global education initiative in factor XI/XIa inhibition

ISTH announces launch of new global education initiative in factor XI/XIa inhibition

The International Society on Thrombosis and Haemostasis (ISTH), the leading worldwide not-for-profit organization dedicated to advancing the...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Publishing & Information Services

Publishing & Information Services

Not For Profit

Not For Profit

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.